P2X7 Receptor-Induced Human Mast Cell Degranulation Is Enhanced by Interleukin 33
International Journal of Molecular Sciences · 31.01.2024 · 25 (3) · 1730
DOI: 10.3390/ijms25031730 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 31.01.2024. Verfasst von Barbora Salcman und 5 weiteren Autor:innen. Beteiligte Einrichtung: Lydia Becker Institute of Immunology and Inflammation, University of Manchester, Manchester M13 9NT, UK. Hauptthemen laut MEDLINE: Cell Degranulation, Interleukin-33, Receptors, Purinergic P2X7. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Medical Research Council, Biotechnology and Biological Sciences Research Council.
Abstract (Originalsprache)
MCs are tissue-resident immune cells that strategically reside in barrier organs and respond effectively to a wide range of stimuli, such as IL-33, a mediator released upon epithelial damage. Adenosine triphosphate (ATP) accumulates at sites of tissue injury and is known to modulate MC activities. This study investigated how an inflammatory tissue environment rich in IL-33 modulates the ATP-mediated activation of MCs. Human primary MCs primed with IL-33 displayed a strongly increased response to ATP but not ADP. This resulted in increased degranulation, IL-8 release, and pERK1/2 signalling. Such effects are unique to IL-33 stimulation and not shared by the epithelial alarmin, TSLP. MC exposure to IL-33 also increased membrane expression of purinergic and ATP-binding P2X receptors. The use of selective P2X receptor inhibitors identified P2X7 receptor as the key mediator of the enhanced ATP-induced ERK1/2 signalling and degranulation in IL-33-primed MCs. Whilst the inhibition of P2X1 and P2X4 receptors had no effect on MC degranulation, inhibiting these receptors together with P2X7 resulted in further decreased MC-mediated degranulation. These data therefore point toward the potential mechanisms by which IL-33 contributes to the modulation of ATP-mediated activation in human MCs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Lydia Becker Institute of Immunology and Inflammation, University of Manchester, Manchester M13 9NT, UK.
- GlaxoSmithKline, Stevenage SG1 2NY, UK.
ORCID-Profile: Peter W West, Silvia Bulfone-Paus
Förderung
- Wellcome Trust
- Medical Research Council
- Biotechnology and Biological Sciences Research Council
Zitieren
APA
Salcman, B., Bahri, R., West, P. W., Tontini, C., Affleck, K., & Bulfone-Paus, S. (2024). P2X7 Receptor-Induced Human Mast Cell Degranulation Is Enhanced by Interleukin 33. International Journal of Molecular Sciences, 25(3), 1730. https://doi.org/10.3390/ijms25031730
Vancouver
Salcman B, Bahri R, West PW, Tontini C, Affleck K, Bulfone-Paus S. P2X7 Receptor-Induced Human Mast Cell Degranulation Is Enhanced by Interleukin 33. International Journal of Molecular Sciences. 2024;25(3):1730. doi:10.3390/ijms25031730
BibTeX
@article{Salcman2024,
author = {Salcman, Barbora and Bahri, Rajia and West, Peter W and Tontini, Chiara and Affleck, Karen and Bulfone-Paus, Silvia},
title = {P2X7 Receptor-Induced Human Mast Cell Degranulation Is Enhanced by Interleukin 33},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {3},
pages = {1730},
doi = {10.3390/ijms25031730}
}
EUVIMED